RxDoctor Payments Data

Matthew Lawrence, DPM

Foot & Ankle Surgery · Pawtucket, RINPI 1770005951

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.2%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Smith+Nephew at 50.8% of the total. Reporting peaked in 2024 at $11,625 and has fallen 88.5% since, to $1,335 in 2025. Among foot & ankle surgery clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$37,663in general payments, 2019–2025

Across 217 payments — averaging $173.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$19K
  • Gramercy Extremity Orthopedics LLC$14K
  • Stryker$2K
  • Orthofix Medical, Inc.$399
  • Polynovo North America LLC$270
  • Misonix Inc$250
  • plus $2K from 20 others
$15,000in ownership & investment interests, 2019–2025

Across 5 payments — averaging $3000.00 each. An ownership or investment interest held by the physician or an immediate family member.

  • Gramercy Extremity Orthopedics LLC$15K

What the payments were for

  • Consulting fees$19,28851%
  • Speaking & faculty fees$9,67526%
  • Travel & lodging$1,4654%
  • Food & beverage$7,23519%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,663 in reported general payments places this provider in the 90th percentile of 58 foot & ankle surgery providers in Rhode Island.

See all foot & ankle surgery providers in Rhode Island

Medicare billing

Part B allowed, 2024
$172,536
Medicare patients
525
Services billed
2,655

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl39$157

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Pawtucket

See the full list for Rhode Island

Where these figures come from

Is this you, or does something look wrong? →